6Nead MA and McCance DJ.Activitier of the Transforming proteits of human papillomaviruse.In McCance DJ (ed.),Human Tumor Viruses.ASM press,Washington,1998,225-251.?A
7Nakagawa S,Yoshikawa.H,Yasugi T,et al.Ubiquitous presence of E6 and E7 transcripts in human papillomavirus positive cervical carcinomas regardless of its type.J Med Virol,2000,62 (2): 251-256.?A
8Choo KB,Wang TS and Human CJ.Analysis of relative binding offinity of E7-pRB of human papillomavirus 16 clinical variants using the yeast two hybrid system.J Med Virol,2000,61(3):298-302.?A
9Luxton J,Mant C,Greenwood B,et al.HPV 16 E6 oncogene variants in women with cervical intraepithelial neoplasia.J Med Virol,2000,60 (3): 337-341.?A
10Wang TS,Chou HF,Liu WM,et al.Semiautomated typing of human papillomaviruse by restriction fragmaent length polymorphism analysis of fluoresence labeled PCR fragments.J Med Virol,1999,59 (4): 536-540.?A
2Coleman N, Birley HD, Renton AM. Immunological events in regressing genital warts. Am J Clin Pathol, 1994, 102(6):768-774.
3Leigh IM, Glover MJ. Cutaneous warts and tumours in immunosuppressed patients. J R Soc Med, 1995, 88(2):61-62.
4Durst M, Bosch FX, Glitz D, et al. Inverse relationship between human papillomavirus(HPV)16 type early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines. J Virol, 1991,65(2):796-804.
5Rueseh MN, Stubenrauch F, Laimins LA. Activation of papillomavirus late gene transcription and genome amplification upon differentation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J Virol,1998,72(6): 5016-5024.
9Xu L, Sanchez A, Yang Z, et al. Immunization for Ebela virus infection. Nat Med, 1998,4(1):37-42.
10Arany I, Goel A, Tyring SK. Interferon response depends on viral transcription in human papillomavirus-containing lesions. Anticancer Res, 1995, 15(6B) :2865-2869.
